Cargando…
Role of the combination of biologics and/or small molecules in the treatment of patients with inflammatory bowel disease
Inflammatory bowel disease (IBD) is a group of chronic diseases that includes ulcerative colitis, Crohn’s disease, and indeterminate colitis. Patients with IBD require prolonged treatment and high utilization of healthcare resources for proper management. The treatment of patients with IBD is focuse...
Autor principal: | Balderramo, Domingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813940/ https://www.ncbi.nlm.nih.gov/pubmed/36620336 http://dx.doi.org/10.3748/wjg.v28.i47.6743 |
Ejemplares similares
-
Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease
por: Xu, Yi-Han, et al.
Publicado: (2022) -
Emerging role of dual biologic therapy for the treatment of inflammatory bowel disease
por: McCormack, Matthew D, et al.
Publicado: (2023) -
Combination therapy for inflammatory bowel disease
por: Sultan, Keith S, et al.
Publicado: (2017) -
Unveiling the biological role of sphingosine-1-phosphate receptor modulators in inflammatory bowel diseases
por: Tourkochristou, Evanthia, et al.
Publicado: (2023) -
Endoscopy in inflammatory bowel disease: Role in diagnosis, management, and treatment
por: Spiceland, Clayton M, et al.
Publicado: (2018)